RIGL Competitors & Alternatives
Compare Rigel Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RIGL
Main Stock$48.85
Tradestie Score
60
Market Cap
$505.12M
P/E Ratio
2.8
Revenue Growth
-0.2%
Analyst Upside
+29.0%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$18.39
|
$917.23M | - | 58 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$17.55
|
$906.29M | - | 55 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$28.35
|
$903.54M | - | 51 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$80.55
|
$900.91M | - | 63 | Compare |
|
GERN
Geron Corp
|
$1.18
|
$899.60M | - | 65 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$47.86
|
$894.30M | - | 54 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$26.63
|
$887.30M | - | 50 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.28
|
$879.90M | 5.5 | 73 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$7.15
|
$871.90M | - | 53 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$9.58
|
$868.46M | - | 45 | Compare |
More RIGL Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry